Respiratory

Latest News

Given the observed outcomes, camlipixant merits further study in severe RCC, especially among patients with a high initial cough burden. | Image credit: sebra - stock.adobe.com
Camlipixant May Benefit Patients With High-Burden RCC

June 25th 2025

A phase 2a trial of camlipixant, a selective P2X3 receptor antagonist, found that while the drug did not significantly reduce cough frequency in the overall population with refractory chronic cough, it produced meaningful improvements in patients with a higher baseline cough burden.

Man having asthma attack on couch | Image credit: Pixel-Shot – stock.adobe.com
Solrikitug Shows Promise as Next-Generation Anti-TSLP Therapy in Asthma, COPD

June 25th 2025

A comprehensive home-based program integrating weekly telecounseling and individually tailored breathing exercise training reduced hospitalizations among patients with COPD. | Image credit: Ahmad - stock.adobe.com
Telehealth Model Reduces Hospital Admissions in COPD

June 18th 2025

FDA Approval | Image credit: BHM – stock.adobe.com
FDA Approves Clesrovimab to Prevent RSV in Infants During First Season

June 10th 2025

In the new report, the authors aimed to see how well the REOM device would perform in a cohort of adults with COPD. | Image credit: Elena - stock.adobe.com
Handheld Device Could Simplify COPD Monitoring

May 28th 2025

Continuing Medical Education
View All
June 30th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
June 30th 2025

Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies

1.0 Credit / Immunology, Pulmonology/Respiratory
June 30th 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health
June 30th 2025

Updated Guidance and Managed Care Strategies to Optimize Respiratory Syncytial Virus Vaccination Coverage

1.5 Credits / Immunization, Infectious Disease, Pulmonology
June 30th 2025

Reflecting on the Real-World Use of Biologic Therapy in Asthma Management

1.5 Credits / Immunology, Pulmonology
June 30th 2025

Advancing Cystic Fibrosis Management: The Evolving Role of Specialty and Managed Care Pharmacists

1.5 Credits / Pulmonology
June 30th 2025

Pulmonary Arterial Hypertension: Real-World Applications of New Therapies and Management Strategies

1.5 Credits / Pulmonology, Cardiology, Rare Diseases

More News

x-ray and stethoscope
February 23rd 2022

Transesophageal Echocardiography Not Linked With Respiratory Failure, Study Finds

Hayden E. Klein
The 28-day cumulative risk of respiratory failure after transesophageal echocardiography (TEE) was similar to the risk measured in those go did not undergo TEE, a procedure performed after a transient ischemic attack or stroke.
lung graphic
February 20th 2022

Small Study Shows 100% Success in Lung Transplants for COVID-19–Associated ARDS

Hayden E. Klein
Survival was 100% among patients who had COVID-19-associated acute respiratory distress syndrome (ARDS), and 83% for those without COVID-19 infection.
Patsy Stinchfield, RN, MS, and William Schaffner, MD
February 16th 2022

NFID Board Members Discuss COVID-19's Impact on RSV Seasonality

Hayden E. Klein
William Schaffner, MD, medical director at the National Foundation for Infectious Diseases (NFID), and Patsy Stinchfield, RN, MS, CPNP, president-elect of NFID, explain how the COVID-19 pandemic has had an impact on the seasonality of respiratory syncytial virus (RSV).
Doctor holding baby
February 14th 2022

Shorter Treatment for Community-Acquired Pneumonia as Effective as Longer Course

Hayden E. Klein
Research suggests a shorter 5-day antibiotic regimen for childhood community-acquired pneumonia, instead of 10 days, can optimize treatment efficacy while reducing unnecessary antibiotic use.
Nurse and patient walking in hospital hallway
February 5th 2022

Study Finds Higher In-Hospital Mortality Risk for Older Patients With Frailty, COVID-19

Hayden E. Klein
Research showed that younger and nonfrail patients with COVID-19 were more likely to be put on a ventilator, while patients with frailty and older age had a higher risk of in-hospital and in-ICU mortality.
coronavirus
February 4th 2022

Controversial Paper Claims COVID-19 "Lockdowns" Had Little Public Health Effect

Laura Joszt, MA
A meta-analysis from 3 economists concluded that nonpharmaceutical interventions in response to COVID-19 failed to have a large, significant effect on mortality rates.
Site Logo
February 3rd 2022

Antibiotic Practice Patterns With Procalcitonin Levels in Patients With Acute Lower Respiratory Tract Infection

Jessica K. Costales-Cantrell, DO, MBS Joanie Chung, MPH Jim H. Nomura, MD Kristen R. Ironside, MS Paul W. Salama, MD John J. Sim, MD
Although clinical trials have demonstrated the utility of procalcitonin (PCT) testing and potential benefit on antibiotic stewardship, findings suggest that clinicians do not order PCT testing with regularity and also prioritize clinical judgment over PCT results.
What We're Reading
February 2nd 2022

What We’re Reading: Cancer Moonshot Returns; New Omicron Subvariant; Drug Overdose Suicide Rates

AJMC Staff
President Biden announced he would bring back the Cancer Moonshot initiative that launched in the Obama administration; the World Health Organization said the Omicron subvariant, BA.2, appears to have the same severity as the original Omicron variant; cases of suicide by drug overdose increased in young people, older adults, and non-Hispanic Black women.
Doctor looking at lung radiography
January 27th 2022

Review Evaluates Factors of Pulmonary Disease Subtype Development

Hayden E. Klein
The review discussed the roles of sex, ancestry, senescence, and aging in the development of nontuberculous mycobacterial pulmonary disease.
What We're Reading
January 26th 2022

What We’re Reading: Long-term COVID-19 Factors; Rhode Island Joins Opioid Settlement Case; EPA and "Cancer Alley"

AJMC Staff
A study found 4 factors may correlate with increased risk of long-term COVID-19; Rhode Island joins opioid settlement against McKesson, AmerisourceBergen, and Cardinal Health; the Environmental Protection Agency announced it will station mobile equipment in Louisiana to measure air pollution.
What we're reading stock photo.
January 25th 2022

What We're Reading: Ineffective COVID-19 Drugs; Panel Advises Fourth Dose in Israel; Physician Mental Health Amid Pandemic

AJMC Staff
FDA significantly restricts the use of 2 COVID-19 monoclonal antibody treatments ineffective against the Omicron variant; an expert panel advises the Israeli government to offer a fourth COVID-19 vaccine dose to adults; there was a substantial increase in visits for mental health and substance abuse among physicians with no prior history during the pandemic.
older woman receiving vaccination
January 19th 2022

Study Highlights Health, Economic Benefits of RSV Vaccine for Older Adults

Hayden E. Klein
With no existing respiratory syncytial virus (RSV) vaccine yet, researchers found that a vaccine comparable with the influenza vaccine could prevent tens of thousands of hospitalizations and deaths per year.
Image of senior woman in hospital
January 14th 2022

UK Study Characterizes Patient, Health Care System Burden From Chronic Cough

Rose McNulty
Chronic cough can have a significant impact on patient quality of life, and recognizing it as an individual condition may help optimize its treatment.
COVID-19 graphic
January 7th 2022

CDC Clarifies New COVID-19 Isolation Protocol, Outlines Efforts to Protect Children

Gianna Melillo
CDC officials clarified the agency's new isolation recommendations for individuals infected with COVID-19 and provided updates on its efforts to reduce pediatric cases among those too young to receive vaccines.
What We're Reading
January 5th 2022

What We’re Reading: US Increases Pfizer Pill Order; California At-Home STI Tests; Supreme Court Hearing on Vaccine Mandates

AJMC Staff
The Biden administration doubled its order of Pfizer’s COVID-19 antiviral drug; California is now the first state to require health insurance plans to cover at-home STI tests; the Supreme Court will hear in-person arguments Friday to decide whether to block federal vaccine mandates.
Top 5 Respiratory Articles of 2021
December 29th 2021

Top 5 Respiratory Content of 2021

Hayden E. Klein
An 8-year journey to a chronic cough diagnosis, neurogenic cough treatment, e-cigarettes, and COVID-19 risk factors were among the most-viewed respiratory articles.
Laurie Slovarp, PhD
December 26th 2021

Dr Laurie Slovarp on the Importance of Early Behavioral Cough Therapy

Laura Joszt, MA
Behavioral cough therapy should be used as early intervention, said Laurie Slovarp, PhD, CCC-SLP, associate professor in the School of Speech, Language, Hearing, and Occupational Sciences at University of Montana.
Timothy C.Pigg, president and CEO, Rotech Healthcare Inc
December 23rd 2021

Contributor: Objective Documentation Protects Patient Access to Home Oxygen Therapy

Timothy C. Pigg
Facing the challenges created by the COVID-19 pandemic, the US medical community has been forced to rapidly change and modernize the manner in which it delivers health care over the last year-and-a-half. 
A Timeline of COVID-19 Vaccine Developments for the Second Half of 2021
December 23rd 2021

A Timeline of COVID-19 Vaccine Developments for the Second Half of 2021

AJMC Staff
Although 2021 closes with a plentiful supply of COVID-19 vaccines and boosters, Americans continue to face challenges with the widespread Omicron variant and new testing hurdles.
Laurie Slovarp, PhD
December 19th 2021

Dr Laurie Slovarp on Preventing and Suppressing Chronic Cough Events

Laura Joszt, MA
Most people are aware of what triggers their chronic cough and how to temporarily suppress it, said Laurie Slovarp, PhD, CCC-SLP, associate professor in the School of Speech, Language, Hearing, and Occupational Sciences at University of Montana.
FDA Approves Tezepelumab for Severe Asthma
December 17th 2021

FDA Approves Tezepelumab for Severe Asthma

Allison Inserro
Laurie Slovarp, PhD
December 12th 2021

Dr Laurie Slovarp Explains How Chronic Cough Impacts Quality of Life

Laura Joszt, MA
Chronic cough can be very debilitating to a patient's quality of life, explained Laurie Slovarp, PhD, CCC-SLP, associate professor in the School of Speech, Language, Hearing, and Occupational Sciences at University of Montana.
Woman using inhaler
December 10th 2021

Asthma Education Linked to Better 1-Year Disease Control Outcomes in Adolescents, Study Finds

Hayden E. Klein
Participation in education sessions and frequent web-based monitoring predicted 1-year outcomes of asthma control for adolescents with partly controlled and uncontrolled asthma.
Peter Dicpinigaitis, MD
December 6th 2021

COVID-19 Not Creating Lingering Chronic Cough Impacts, Dr Peter Dicpinigaitis Says

Peter Dicpinigaitis, MD, professor of medicine at the Albert Einstein College of Medicine and director of the Montefiore Cough Center, discusses what he and others have seen during the pandemic in patients with chronic cough who had COVID-19.
Electrical treatment
December 3rd 2021

TENS Has Potential as a Treatment for Chronic Cough, Small Study Finds

Hayden E. Klein
A small study found that patients with chronic cough saw improvements in symptoms following transcutaneous electrical nerve stimulation treatment, with minimal adverse effects.
Doctor with patient
December 2nd 2021

FeNO Values Linked to ICS Therapy Response Rates in Patients With Chronic Cough

Hayden E. Klein
A systematic review showed that a high fractional exhaled nitric oxide (FeNO) value before starting inhaled corticosteroid (ICS) therapy may be associated with higher response rates in patients with chronic cough.
lung graphic
November 27th 2021

Potential Markers of COVID-19 Severity Found Among Patients With Chronic Airway Diseases

Gianna Melillo
Results of a retrospective study revealed potential markers of COVID-19 severity among those with chronic obstructive pulmonary disease, asthma, or chronic bronchitis.
Woman with heartburn
November 24th 2021

Heartburn Can Predict Acid Suppression Success in Chronic Cough, Study Finds

Hayden E. Klein
Despite a relatively low response rate to acid suppression therapy to treat chronic cough, heartburn was a highly significant predictor of success.
Nurse with patient in nursing home
November 20th 2021

Poor Nutritional Status May Predict High Pneumonia Risk in Elderly, Study Finds

Hayden E. Klein
The prognosis was worse in patients with basic dementia or Alzheimers disease as well as chronic obstructive pulmonary disease or asthma.
Doctor treating man with inhaler
November 19th 2021

Bronchial Hyperresponsiveness May Predict Cough-Variant Asthma in Adults With Chronic Cough

Hayden E. Klein
The study found that cough severity and cough-related quality of life were not related to the severity of bronchial hyperresponsiveness in nonsmoking adults with cough-variant asthma.
<1
...
34567891011
...
22>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo